| Systematic review of levodopa dose equivalency reporting in Parkinson's disease CL Tomlinson, R Stowe, S Patel, C Rick, R Gray, CE Clarke Movement disorders 25 (15), 2649-2653, 2010 | 4233 | 2010 |
| A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang New England Journal of Medicine 342 (20), 1484-1491, 2000 | 1999 | 2000 |
| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1646 | 2019 |
| Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial A Williams, S Gill, T Varma, C Jenkinson, N Quinn, R Mitchell, R Scott, ... The Lancet Neurology 9 (6), 581-591, 2010 | 855 | 2010 |
| Physiotherapy versus placebo or no intervention in Parkinson's disease CL Tomlinson, S Patel, C Meek, CP Herd, CE Clarke, R Stowe, L Shah, ... Cochrane database of systematic reviews, 2013 | 710 | 2013 |
| Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine IJ Mitchell, CE Clarke, S Boyce, RG Robertson, D Peggs, MA Sambrook, ... Neuroscience 32 (1), 213-226, 1989 | 539 | 1989 |
| Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PD Med Collaborative Group The Lancet 384 (9949), 1196-1205, 2014 | 435 | 2014 |
| Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis CL Tomlinson, S Patel, C Meek, CP Herd, CE Clarke, R Stowe, L Shah, ... Bmj 345, 2012 | 426 | 2012 |
| Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ... The American Journal of Human Genetics 98 (3), 500-513, 2016 | 415 | 2016 |
| Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ... Brain 140 (12), 3191-3203, 2017 | 393 | 2017 |
| Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ... Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014 | 380 | 2014 |
| Physiotherapy for Parkinson's disease: a comparison of techniques CL Tomlinson, CP Herd, CE Clarke, C Meek, S Patel, R Stowe, ... Cochrane Database of Systematic Reviews, 2014 | 376* | 2014 |
| Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study AJ Sinclair, MA Burdon, PG Nightingale, AK Ball, P Good, TD Matthews, ... Bmj 341, 2010 | 375 | 2010 |
| Idiopathic intracranial hypertension AK Ball, CE Clarke The Lancet Neurology 5 (5), 433-442, 2006 | 367 | 2006 |
| Dopamine agonist therapy in early Parkinson's disease R Stowe, N Ives, CE Clarke, J Ferreira, RJ Hawker, L Shah, K Wheatley, ... Cochrane Database of Systematic Reviews, 2008 | 305 | 2008 |
| A two-stage meta-analysis identifies several new loci for Parkinson's disease International Parkinson's Disease Genomics Consortium (IPDGC), ... PLoS genetics 7 (6), e1002142, 2011 | 262* | 2011 |
| Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study M Pechevis, CE Clarke, P Vieregge, B Khoshnood, ... European Journal of Neurology 12 (12), 956-963, 2005 | 248 | 2005 |
| Rotigotine transdermal patch in early Parkinson's disease: a randomized, double‐blind, controlled study versus placebo and ropinirole N Giladi, B Boroojerdi, AD Korczyn, DJ Burn, CE Clarke, AHV Schapira, ... Movement disorders 22 (16), 2398-2404, 2007 | 243 | 2007 |
| Parkinson's disease CE Clarke Bmj 335 (7617), 441-445, 2007 | 233 | 2007 |
| Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease LL Kilarski, JP Pearson, V Newsway, E Majounie, MDW Knipe, ... Movement Disorders 27 (12), 1522-1529, 2012 | 212 | 2012 |
